Jenerise is a B2B creatine innovation and education company that provides high-purity, independently verified creatine ingredients and develops next-generation delivery technologies, including liquid-stable formats, for the global wellness market.
Jenerise is a UK-based creatine innovation and education company founded in 2024 by father-daughter duo Steve and Rachael Jennings. Operating primarily as a B2B ingredient technology brand, the company aims to modernize the creatine category by prioritizing precision-grade quality and scientific education. Its flagship product, Cr.01, is a high-purity creatine monohydrate ingredient that is independently verified lot-by-lot by SGS for quality assurance. Beyond ingredient supply, Jenerise is actively developing advanced creatine delivery technologies, including patent-pending liquid-stable formulations, intended to expand the use of creatine into ready-to-drink, ready-to-mix, and ready-to-eat applications.
The company seeks to broaden the market for creatine, moving it from a niche supplement for athletes to a staple for everyday wellness, cognitive health, and aging. To achieve this, Jenerise provides educational resources through its Jenerise Education platform, which offers science-backed webinars and workshops for brands, schools, and healthcare practitioners. By partnering with industry distributors and consumer brands, Jenerise aims to increase global daily creatine usage by providing a traceable, high-quality standard that addresses the gap between extensive scientific research and mainstream consumer availability.